Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ...

Lupin gets USFDA nod for Ipratropium Bromide Nasal Solution (0.03%) under abbreviated new drug application (ANDA). The approved drug is a generic of Atrovent Nasal Spray (0.03%) (Boehringer Ingelheim ...

Medical Dialogues team had earlier reported that Lupin had received USFDA approval for its ANDA for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.06%, to market a generic equivalent of Atrovent ...

Markets began the week on a feeble note, losing nearly a percent due to unfavorable global cues and mixed earnings reports. In today's trade, shares of Nykaa, Vodafone Idea, Apollo Hospitals ...

Lupin: The company has obtained approval from the U.S. FDA for its Abbreviated New Drug Application for Ipratropium Bromide Nasal Solution. Shriram Properties: The company has entered into a Joint ...

Shares of Vodafone Idea, SAIL, IRCTC, Tata Investment and Ircon will be in focus as the companies will announce their third quarter results today. Hindalco's arm Novelis reported a net profit of $110 ...

Indian equities face short-term volatility, but Emkay Institutional Equities predicts the Nifty index will hit 25,000 by December 2025. A gradual consumption recovery, driven by improved employment ...

When chlorine (as a gas or dissolved in water) is added to sodium bromide solution, the chlorine takes the place of the bromine. Because chlorine is more reactive than bromine, it displaces ...